Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
LumiraDx logo — Transforming community-based healthcare through POC diagnost...

LumiraDx

Transforming community-based healthcare through POC diagnostics & making lab-comparable tests accessible to all

Founded 2014 United Kingdom London, United Kingdom 338 employees IPO Total: $825.47M Health Care, Medical Devices

General Information

Company Name LumiraDx
Founded Year 2014
Location United Kingdom London, United Kingdom +2
Founders / Decision Makers
Giffin Daughtridge, MD, MBA Daughtridge — VP/GM
Employees 338
Industries Health Care, Medical Devices
Funding Stage IPO
Social

Get notified when LumiraDx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About LumiraDx

LumiraDx, established in 2014 and headquartered in the United Kingdom, operates within the Health Care and Medical Devices sectors. The company has rapidly gained attention for its groundbreaking technology designed to transform community-based healthcare through point-of-care (POC) diagnostics, making lab-comparable tests accessible to all.

A significant leap was marked by the acquisition of LumiraDx's next-generation POC platform technology by Roche Diagnostics, a global leader in personalized healthcare and a pioneer in pharmaceuticals and diagnostics. This acquisition promises to leverage combined expertise to continue delivering innovative patient solutions.

The company previously secured a $14.20M grant investment on 01 December 2022, backed by the Bill & Melinda Gates Foundation, underscoring investor confidence in LumiraDx's potential to revolutionize healthcare diagnostics.

Taxonomy: Point-of-Care Diagnostics, Lab-comparable Tests, Personalized Healthcare, In Vitro Diagnostics, Tissue-based Cancer Diagnostics, Diabetes Management, Pharmaceuticals, Health Information Exchange, Clinical Integration, Population Health Management, Interoperability, Patient-centered Care, Digital Connectivity, Healthcare Innovation

Services & Products

Diagnostic Solutions
Digital Solutions
Workflow Integration and Connectivity
Assays and Detection
Health Topics

Target Customers

Healthcare Professionals Researchers General Audiences Primary Care Settings Decentralized Healthcare Settings

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $14.20M 1
Bill & Melinda Gates Foundation
01 Dec 2022
Post Ipo Convertible $56.50M - 01 Mar 2022
Spac Private Placement $115.00M 1 CA Healthcare Acquisition Corp 01 Sep 2021
Post Ipo Debt $400.00M 2
BioPharma Credit PLC
Plus Capital One 		01 May 2021
Late Vc $164.00M - 01 Dec 2020

View All 7 Funding Rounds

LumiraDx Alternatives & Competitors

View All Alternatives
LumiraDx vs
Roche
Roche Switzerland

We advance science so that we all have more time with the people we love. Are you ready to join us?

IPO
108383 employees
Pharmaceutical
Compare LumiraDx vs Roche
LumiraDx vs
Siemens Healthineers
Siemens Healthineers Germany

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably.

53999 employees
Manufacturing, Pharmaceutical
Compare LumiraDx vs Siemens Healthineers
LumiraDx vs
Monogram Biosciences
Monogram Biosciences United States

Monogram Biosciences, a LabCorp company, is a leader in developing and commercializing innovative pr...

202 employees
Biotechnology, Health Care
Also compare with: LumiraDx vs EKF Diagnostics EKF Diagnostics View all alternatives

FAQ About LumiraDx

Transforming community-based healthcare through POC diagnostics & making lab-comparable tests accessible to all
LumiraDx was founded in 2014.
LumiraDx is headquartered in London, United Kingdom.
LumiraDx operates in the following industries: Health Care, Medical Devices.
LumiraDx has approximately 338 employees.
LumiraDx has completed 7 funding rounds, raising a total of $825.47M. The latest funding stage is IPO.
LumiraDx offers: Diagnostic Solutions, Digital Solutions, Workflow Integration and Connectivity, Assays and Detection, Health Topics.
Top alternatives and competitors to LumiraDx include Roche, Siemens Healthineers, Monogram Biosciences, EKF Diagnostics, Getwell Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LumiraDx and Roche are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors LumiraDx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy